Qube Research & Technologies LTD An2 Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.93 - $3.76 $77,545 - $151,073
-40,179 Reduced 79.78%
10,186 $21,000
Q1 2024

May 14, 2024
SELL
$2.78 - $21.53 $60,723 - $470,279
-21,843 Reduced 30.25%
50,365 $163,000
Q4 2023

Feb 13, 2024
BUY
$13.92 - $21.0 $1.01 Million - $1.52 Million
72,208 New
72,208 $1.48 Million
Q2 2023

Aug 14, 2023
BUY
$5.06 - $9.91 $92,906 - $181,957
18,361 New
18,361 $156,000

Others Institutions Holding ANTX

# of Institutions
33
Shares Held
13.5M
Call Options Held
0
Put Options Held
0
View Full List

About AN2 Therapeutics, Inc.

ANTX Quotes by TradingView
  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $26M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email